World's Best Scientists 2026 revealed!
Kenji Kabashima

Kenji Kabashima

D-Index & Metrics

Immunology

D-Index
102
Citations
39080
World Ranking
672
National Ranking
19

Medicine

D-Index
102
Citations
39139
World Ranking
7646
National Ranking
185

Kenji Kabashima publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Kenji Kabashima sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 959 publications — 99th percentile

99% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Kenji Kabashima D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Kenji Kabashima sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 102 D-Index — 87th percentile

87% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Kenji Kabashima is affiliated with Kyoto University in Japan and has contributed extensively to the field of medicine, particularly focusing on dermatology and immunology. Their research covers a range of topics within these areas, reflecting an emphasis on skin diseases, allergic conditions, and immune system mechanisms.

The main fields of study associated with Kenji Kabashima include:

  • Medicine

Within this broad field, their work spans several subfields:

  • Dermatology
  • Immunology
  • Immunology and Allergy
  • Rheumatology
  • Physiology

Key topics that have been central to their research include:

  • Dermatology and Skin Diseases
  • Allergic Rhinitis and Sensitization
  • Asthma and respiratory diseases
  • Urticaria and Related Conditions
  • Autoimmune Bullous Skin Diseases
  • Food Allergy and Anaphylaxis Research
  • IL-33, ST2, and ILC Pathways

Kenji Kabashima has published research in numerous scientific venues. The most frequent publication venues are:

  • The Journal of Dermatology
  • Journal of Investigative Dermatology
  • Journal of the European Academy of Dermatology and Venereology
  • Journal of Allergy and Clinical Immunology
  • British Journal of Dermatology

Collaboration has been a significant aspect of their scientific work. Frequent co-authors include:

  • Takashi Nomura
  • Saeko Nakajima
  • Gyohei Egawa
  • Emma Guttman-Yassky
  • Satoshi Nakamizo

Notable recent papers authored or co-authored by Kenji Kabashima include:

  • "Trial of Nemolizumab and Topical Agents for Atopic Dermatitis with Pruritus," 2020, New England Journal of Medicine
  • "Type 2 immunity in the skin and lungs," 2020, Allergy
  • "Safety and efficacy of upadacitinib in combination with topical corticosteroids in adolescents and adults with moderate-to-severe atopic dermatitis (AD Up): results from a randomised, double-blind, placebo-controlled, phase 3 trial," 2021, The Lancet
  • "Baricitinib in patients with moderate-to-severe atopic dermatitis and inadequate response to topical corticosteroids: results from two randomized monotherapy phase III trials," 2020, British Journal of Dermatology
  • "Biomarkers in atopic dermatitis-a review on behalf of the International Eczema Council," 2021, Journal of Allergy and Clinical Immunology

Best Publications

  • Atopic dermatitis

    Unknown

  • Anti-PD-1 and Anti-CTLA-4 Therapies in Cancer: Mechanisms of Action, Efficacy, and Limitations.

    Judith A. Seidel;Atsushi Otsuka;Kenji Kabashima;Kenji Kabashima

  • Prostaglandin D2 as a Mediator of Allergic Asthma

    Toshiyuki Matsuoka;Masakazu Hirata;Hiroyuki Tanaka;Yoshimasa Takahashi

  • Two distinct interstitial macrophage populations coexist across tissues in specific subtissular niches

    Svetoslav Chakarov;Hwee Ying Lim;Leonard Tan;Sheau Yng Lim

  • Possible pathogenic role of Th17 cells for atopic dermatitis.

    Chizuko Koga;Kenji Kabashima;Noriko Shiraishi;Miwa Kobayashi

  • Tumor cell expression of programmed cell death-1 ligand 1 is a prognostic factor for malignant melanoma†

    Ryosuke Hino;Kenji Kabashima;Kenji Kabashima;Yu Kato;Hiroaki Yagi

  • The Asian atopic dermatitis phenotype combines features of atopic dermatitis and psoriasis with increased TH17 polarization.

    Shinji Noda;Mayte Suárez-Fariñas;Benjamin Ungar;Benjamin Ungar;Soo Jung Kim

  • Anti-interleukin-31 receptor a antibody for atopic dermatitis

    Thomas Ruzicka;Jon M. Hanifin;Masutaka Furue;Grazyna Pulka

  • The immunological anatomy of the skin

    Kenji Kabashima;Kenji Kabashima;Tetsuya Honda;Florent Ginhoux;Florent Ginhoux;Gyohei Egawa

  • The prostaglandin receptor EP4 suppresses colitis, mucosal damage and CD4 cell activation in the gut

    Kenji Kabashima;Tomomi Saji;Takahiko Murata;Miyako Nagamachi

  • Type 2 immunity in the skin and lungs.

    Cezmi A. Akdis;Peter D. Arkwright;Marie-Charlotte Brüggen;William Busse

  • Germline NLRP1 Mutations Cause Skin Inflammatory and Cancer Susceptibility Syndromes via Inflammasome Activation

    Franklin L. Zhong;Ons Mamaï;Lorenzo Sborgi;Lobna Boussofara

  • New concept of the pathogenesis of atopic dermatitis: interplay among the barrier, allergy, and pruritus as a trinity.

    Kenji Kabashima

  • The epithelial immune microenvironment (EIME) in atopic dermatitis and psoriasis.

    Teruki Dainichi;Akihiko Kitoh;Atsushi Otsuka;Saeko Nakajima

  • Update of Immune Events in the Murine Contact Hypersensitivity Model: Toward the Understanding of Allergic Contact Dermatitis

    Tetsuya Honda;Gyohei Egawa;Stephan Grabbe;Kenji Kabashima

  • Baricitinib in patients with moderate-to-severe atopic dermatitis and inadequate response to topical corticosteroids: results from two randomized monotherapy phase III trials

    Eric L. Simpson;J.‐P. Lacour;L. Spelman;R. Galimberti

  • Increasing Comorbidities Suggest that Atopic Dermatitis Is a Systemic Disorder.

    Patrick M. Brunner;Jonathan I. Silverberg;Emma Guttman-Yassky;Amy S. Paller

  • Prostaglandin E2-EP4 signaling initiates skin immune responses by promoting migration and maturation of Langerhans cells.

    Kenji Kabashima;Daiji Sakata;Miyako Nagamachi;Yoshiki Miyachi

  • Intrinsic Lymphotoxin-β Receptor Requirement for Homeostasis of Lymphoid Tissue Dendritic Cells

    Kenji Kabashima;Theresa A. Banks;K. Mark Ansel;Theresa T. Lu

  • Safety and efficacy of upadacitinib in combination with topical corticosteroids in adolescents and adults with moderate-to-severe atopic dermatitis (AD Up): results from a randomised, double-blind, placebo-controlled, phase 3 trial.

    Kristian Reich;Henrique D Teixeira;Marjolein de Bruin-Weller;Thomas Bieber

  • Stress-induced production of chemokines by hair follicles regulates the trafficking of dendritic cells in skin

    Keisuke Nagao;Tetsuro Kobayashi;Kazuyo Moro;Manabu Ohyama

  • Activated regulatory T cells are the major T cell type emigrating from the skin during a cutaneous immune response in mice

    Michio Tomura;Tetsuya Honda;Hideaki Tanizaki;Atsushi Otsuka

Frequent Co-Authors

Yoshiki Miyachi
Yoshiki Miyachi Kyoto University
Takashi Nomura
Takashi Nomura Kyoto University
Shuh Narumiya
Shuh Narumiya Kyoto University
Emma Guttman-Yassky
Emma Guttman-Yassky Icahn School of Medicine at Mount Sinai
Masayuki Amagai
Masayuki Amagai Keio University
Yukihiko Sugimoto
Yukihiko Sugimoto Kumamoto University
Takashi Hashimoto
Takashi Hashimoto Osaka Metropolitan University
Gary M. Halliday
Gary M. Halliday University of Sydney

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in Immunology, exploring related healthcare degrees can offer diverse career opportunities. Many students consider programs like nurse practitioner degrees, which provide a flexible path into patient care and advanced clinical roles. Choosing the which nurse practitioner program is easiest can help balance rigorous study with career goals.

Specializing further, Psychiatric Mental Health Nurse Practitioner (PMHNP) programs are crucial for those focusing on mental health, a field closely linked with immunological research. Prospective students should look into the top online pmhnp programs to ensure strong clinical experiences. Additionally, affordability remains important, so exploring the cheapest psychiatric nurse practitioner programs can make advanced education more accessible.

Completing a Doctor of Nursing Practice (DNP) degree can significantly impact earning potential and job prospects. Understanding the doctor of nursing practice salary across states aids in planning a sustainable career path post-graduation.

By integrating immunology knowledge with these allied healthcare degrees, graduates can pursue meaningful roles in clinical research, patient care, and healthcare leadership.

Best Scientists Citing Kenji Kabashima

Trending Scientists

Recently Published Articles